(NYSE: BAX) Baxter International's forecast annual revenue growth rate of 2.74% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 12.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.42%.
Baxter International's revenue in 2026 is $11,023,000,000.On average, 19 Wall Street analysts forecast BAX's revenue for 2026 to be $5,866,918,902,465, with the lowest BAX revenue forecast at $5,599,095,828,060, and the highest BAX revenue forecast at $6,214,934,682,450. On average, 17 Wall Street analysts forecast BAX's revenue for 2027 to be $6,042,211,931,970, with the lowest BAX revenue forecast at $5,611,433,167,380, and the highest BAX revenue forecast at $6,400,508,828,055.
In 2028, BAX is forecast to generate $6,021,649,699,770 in revenue, with the lowest revenue forecast at $5,842,758,279,630 and the highest revenue forecast at $6,260,171,593,290.